Arno Andrew

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$934,983.09
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Arno Andrew

According to the SEC Form 4 filings, Arno Andrew, being in a position of

  1. director at OncoCyte Corporation,
    оver the last 12 months, has bought 33898 shares for $99,999, and sold 0 shares,
    over all time since 2018-07-26, has bought 611815 shares for $830,281, and sold 0 shares.

The largest purchase of all time was on 2018-07-26 and amounted to 104894 shares of OncoCyte Corporation for $307,339.

Biography of Arno Andrew

No biography is available at this moment.

2024-04-11PurchaseOncoCyte Corporation
OCX
director
33,898
0.4083%
$2.95$99,999-0.51%
2022-12-23PurchaseOncoCyte Corporation
OCX
director
250,000
0.2087%
$0.35$87,875-43.42%
2022-08-17PurchaseOncoCyte Corporation
OCX
7,500
0.0065%
$0.90$6,750-58.47%
2022-08-17PurchaseSmith Micro Software, Inc.
SMSI
7,500
0.0131%
$2.29$17,206-13.98%
2022-08-15PurchaseOncoCyte Corporation
OCX
115,523
0.0974%
$0.97$112,057-61.86%
2019-09-17PurchaseOncoCyte Corporation
OCX
director
100,000
0.1944%
$2.16$216,260-2.34%
2018-07-26PurchaseOncoCyte Corporation
OCX
director
104,894
0.2681%
$2.93$307,339-12.63%
2011-08-25PurchaseSmith Micro Software, Inc.
SMSI
director
33,801
0.0946%
$1.75$59,152-2.86%
2011-08-24PurchaseSmith Micro Software, Inc.
SMSI
director
16,199
0.0443%
$1.75$28,345-5.03%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.